EAPS 2024 | EAP & ESPR |VIENNA, AUSTRIA & ONLINE

17 - 20 October 2024

This Event Passed

ADDRESS

Austria Center Vienna
Bruno-Kreisky-Platz 1, 1220
Wien, 1220
Austria

Theme: “Harmony between cutting edge research and clinical care”

Dear Colleagues,

It is an honour and pleasure to invite you all to the 10th Congress of the European Academy of Paediatric Societies, EAPS 2024 in Vienna: “Harmony between cutting edge research and clinical care”.

The Congress is organised by the two leading European societies: the European Academy of Paediatrics (EAP), and the European Society for Paediatric Research (ESPR). The combined efforts and talents of the best and brightest minds in paediatrics will make this biannual event a major, leading educational and research platform.We will bring you the latest cutting-edge science and provide attendees with the latest insights and tools that you can bring to your patients, and their families.

In EAPS 2024 we wish to move forward with the best research available today, with a focus on cutting edge science; including the latest in genomics, multi-omics, gene therapy, and machine learning analysis of big data to answer questions which are affected real children in Europe and beyond. We are determined to have an inclusive conference with global representation and contribution.We will explore how these advances can be brought into the clinical to help today’s children: supporting to become the healthy adults of the future. Building on the historic musical history of Vienna our theme for the congress will be to achieve harmony between cutting edge research and real clinical care.

A central feature of the Congress are the free scientific papers presenting new information from all areas of paediatric medicine and child health coming from young and upcoming paediatric stars. These presentations facilitate robust debates, thoughtful conversations, and fruitful collaborations, with the future of our patients and our specialty of paediatrics being brought to the next level. What is more, all accepted abstracts will be published in a peer-reviewed paediatric journal. Mentorship and the development of young researchers is another core theme of the congress.

EAPS 2024 is an excellent platform where you can strengthen, renew existing and make new, life lasting personal and professional relationships. An exciting social and musical programme will also be guaranteed.

The Congress Venue is the Austria Centre in Vienna.

Vienna is a truly exciting city that has numerous facets to explore and enjoy. Please take some relaxing time to find the balance between learning and well-being.

Mark your calendars for EAPS in Vienna, 17-20 October 2024.

We are looking forward to welcoming you all there.

Best Wishes,

Adamos Hadjipanayis (EAP)

Chair, Organising Committee

Deirdre Murray (ESPR)

Chair, Scientific Committee

Your Enquiries Are Welcome

We will respond to you by Email

Core-MD Project

Coordinating Research and Evidence for Medical Devices (CORE-MD)

New ways to test high-risk medical devices.

 

Manufacturers of medical devices need to test their products before being allowed to market them. Specifically, they require clinical data showing their medical device is safe and efficient. In this context, the EU-funded CORE-MD project will translate expert scientific and clinical evidence on study designs for evaluating high-risk medical devices into advice for EU regulators. The project will propose how new trial designs can contribute and suggest ways to aggregate real-world data from medical device registries.


It will also conduct multidisciplinary workshops to propose a hierarchy of levels of evidence from clinical investigations, as well as educational and training objectives for all stakeholders, to build expertise in regulatory science in Europe. CORE–MD will translate expert scientific and clinical evidence on study designs for evaluating high-risk medical devices into advice for EU regulators, to achieve an appropriate balance between innovation, safety, and effectiveness. A unique collaboration between medical associations, regulatory agencies, notified bodies, academic institutions, patients’ groups, and health technology assessment agencies, will systematically review methodologies for the clinical investigation of high-risk medical devices, recommend how new trial designs can contribute, and advise on methods for aggregating real-world data from medical device registries with experience from clinical practice The consortium is led by the European Society of Cardiology and the European Federation of National Associations of Orthopaedics and Traumatology, and involves all 33 specialist medical associations that are members of the Biomedical Alliance in Europe.

EAP Representative: